12 Patents
- US126007832026Anti-new York Esophageal Squamous Cell Carcinoma 1 (NY-ESO-1) Antigen-binding Proteins and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US126007932026Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US125839392026Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - US122972572025Multispecific Antigen-binding Molecules and Uses Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites - US122584122025Nucleic Acid Molecules Encoding Bispecific Anti-bcma X Anti-cd3 Antibodies
Regeneron Pharmaceuticals, Inc.
0 cites - US121509592024Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US121152162024Anti-human Papillomavirus (HPV) Antigen-binding Proteins and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US119589102024Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US116335012023Anti-steap2 Antibodies, Antibody-drug Conjugates, and Bispecific Antigen-binding Molecules That Bind STEAP2 and CD3, and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US115595762023Anti-human Papillomavirus (HPV) Antigen-binding Proteins and Methods of Use Thereof
Regeneran Pharmaceuticals, Inc.
0 cites